Helvetica Chimica Acta – Vol. 91 (2008)
1861
Extraction and Isolation. The dried whole plants of Swertia japonica (2.0 kg) were extracted three
times (14 d each time) with MeOH at r.t., and the extracts were filtered. The MeOH extracts were then
concentrated to give a residue (474.0 g), which was partitioned between H2O and CHCl3. The CHCl3-
soluble fraction was concentrated to afford a residue (308.0 g). A part of this residue (17.8 g) was
subjected to CC (SiO2, CHCl3/MeOH 19 :1 ! 2 :1): Fractions 1 – 20 (by TLC). Fr. 13 was methylated
with TMSCHN2 to give the corresponding methyl esters. The methyl ester mixture was subjected to CC
(SiO2, hexane/AcOEt 4 :1, CHCl3/MeOH 19 :1 ! 4 :1): Fr. 1’ – 20’ (by TLC). Fr. 5’, on prep. HPLC
(hexane/i-PrOH 300 :1) gave 0.4 mg of 11a (tR 105.0) and 0.4 mg of 12a (tR 126.3). Fr. 6’, on prep. HPLC
(hexane/i-PrOH 60 :1) gave 1.2 mg of 6a (tR 17.0), 0.2 mg of 1a (tR 19.3), 1.3 mg of 5a (tR 20.8), and
0.5 mg of 2a (tR 25.0). Fr. 7’, on prep. HPLC (hexane/i-PrOH 60 :1) gave 0.6 mg of 13a (tR 16.5), 1.0 mg of
7a (tR 18.1), a mixture 9a/10a/14a (tR 21.0), 0.3 mg of 4a (tR 21.6), 1.1 mg of 8a (tR 24.4), and 1.0 mg of 3a
(tR 34.4). The mixture 9a/10a/14a, on prep. HPLC (hexane/ i-PrOH 300 :1) gave 0.4 mg of 9a (tR 197.0),
0.4 mg of 10a (tR 266.0), and 0.3 mg of 14a (tR 338.0).
(9Z,12S,13E,15Z)-12-Hydroxyoctadeca-9,13,15-trienoic Acid Methyl Ester (10a): Colorless oil. UV
(MeOH): Table. CD (MeOH): Table. IR (CHCl3): 3602, 1731. 1H-NMR (600 MHz, CDCl3): 1.00 (t, J ¼
7.6, Me(18)); 2.05 (br. q, J ¼ 7.1, CH2(8)); 2.18 – 2.24 (m, CH2(17)); 2.30 (t, J ¼ 7.6, CH2(2)); 2.28 – 2.32 (m,
CH2(11)); 3.67 (s, MeO); 4.19 – 4.23 (m, HÀC(12)); 5.39 (dt, J ¼ 10.7, 7.6, HÀC(10)); 5.45 (dt, J ¼ 11.0,
7.6, HÀC(16)); 5.56 (dt, J ¼ 10.7, 7.3, HÀC(9)); 5.69 (dd, J ¼ 15.1, 6.6, HÀC(13)); 5.94 (t, J ¼ 11.0,
HÀC(15)); 6.53 (dd, J ¼ 15.1, 11.0, HÀC(14)). 13C-NMR (150 MHz, CDCl3): 14.2 (C(18)); 21.1 (C(17));
24.9 (C(3)); 27.4 (C(8)); 29.1 (C(5), C(6), C(7)); 29.5 (C(4)); 34.1 (C(2)); 35.4 (C(11)); 51.5 (MeO); 72.2
(C(12)); 124.4 (C(10)); 125.8 (C(16)); 127.1 (C(15)); 133.6 (C(13)); 134.6 (C(14)); 135.0 (C(9)); 174.3
.
.
(C(1)). HR-EI-MS: 308.2360 (Mþ , C19H32O3þ ; calc. 308.2351).
(9Z,12Z,14E,16R)-16-Hydroxyoctadeca-9,12,14-trienoic Acid Methyl Ester (13a): Colorless oil. UV
(MeOH): Table. CD (MeOH): Table. IR (CHCl3): 3599, 1731. 1H-NMR (600 MHz, CDCl3): 0.88 (t, J ¼
7.1, Me(18)); 2.06 (br. q, J ¼ 7.0, CH2(8)); 2.31 (t, J ¼ 7.7, CH2(2)); 2.93 (br. t, J ¼ 7.7, CH2(11)); 3.67 (s,
MeO); 4.09 – 4.13 (m, HÀC(16)); 5.34 – 5.38 (m, HÀC(10)); 5.39 – 5.43 (m, HÀC(9), HÀC(12)); 5.69
(dd, J ¼ 15.0, 7.0, HÀC(15)); 6.00 (t, J ¼ 11.0, HÀC(13)); 6.52 (dd, J ¼ 15.0, 11.0, HÀC(14)). 13C-NMR
(150 MHz, CDCl3): 9.7 (C(18)); 25.0 (C(3)); 26.1 (C(11)); 27.2 (C(8)); 29.1 (C(5), C(6), C(7)); 29.5
(C(4)); 30.2 (C(17)); 34.1 (C(2)); 51.5 (MeO); 74.2 (C(16)); 125.7 (C(14)); 127.2 (C(10)); 127.8 (C(13));
.
.
130.7 (C(12)); 130.8 (C(9)); 136.1 (C(15)); 174.4 (C(1)). HR-EI-MS: 308.2363 (Mþ , C19H32O3þ
;
calc. 308.2351).
MTPA Esterification of 9a, 10a, 13a, and 14a. To a soln. of each methyl ester 9a (0.4 mg), 10a
(0.4 mg), 13a (0.3 mg), and 14a (0.3 mg) in pyridine (20 ml), (S)-MTPA-Cl (1.7 ml) was added. Each
mixture was allowed to stand at r.t. for 24 h. Next, [(3-dimethylamino)propyl]amine (1.0 ml) was added,
and after 30 min, the mixture was concentrated and the residue purified by prep. HPLC (TSKgel-Silica-
60 column (300 Â 7.8 mm ; Tosoh), hexane/acetone 9 :1, l 230 nm) to give the (R)-MTPA esters 9b
(0.3 mg), 10b (0.3 mg), 13b (0.2 mg), and 14b (0.2 mg) from 9a, 10a, 13a, and 14a, resp.
Data of 9b: 1H-NMR (400 MHz, CDCl3): 0.98 (t, J ¼ 7.6, Me(18)); 2.01 (br. q, J ¼ 7.1, CH2(8)); 2.11 –
2.15 (m, CH2(17)); 2.43 – 2.47 (m, 1 H of CH2(11)); 2.49 – 2.53 (m, 1 H of CH2(11)); 5.35 (dt, J ¼ 10.7, 7.6,
HÀC(10)); 5.87 (t, J ¼ 11.0, HÀC(15)); 6.52 (dd, J ¼ 15.1, 11.0, HÀC(14)).
Data of 10b: 1H-NMR (400 MHz, CDCl3): 1.00 (t, J ¼ 7.6, Me(18)); 1.93 (br. q, J ¼ 7.1, CH2(8));
2.16 – 2.20 (m, CH2(17)); 2.38 – 2.42 (m, 1 H of CH2(11)); 2.43 – 2.47 (m, 1 H of CH2(11)); 5.23 (dt, J ¼
10.7, 7.6, HÀC(10)); 5.92 (t, J ¼ 11.0, HÀC(15)); 6.61 (dd, J ¼ 15.1, 11.0, HÀC(14)).
Data of 13b: 1H-NMR (400 MHz, CDCl3): 0.85 (t, J ¼ 7.1, Me(18)); 2.91 (br. t, J ¼ 7.7, CH2(11)); 5.63
(dd, J ¼ 15.0, 7.0, HÀC(15)); 5.97 (t, J ¼ 11.0, HÀC(13)); 6.64 (dd, J ¼ 15.0, 11.0, HÀC(14)).
Data of 14b: 1H-NMR (400 MHz, CDCl3): 0.94 (t, J ¼ 7.1, Me(18)); 2.87 (br. t, J ¼ 7.7, CH2(11)); 5.53
(dd, J ¼ 15.0, 7.0, HÀC(15)); 5.93 (t, J ¼ 11.0, HÀC(13)); 6.57 (dd, J ¼ 15.0, 11.0, HÀC(14)).